ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Bariatric Surgery Cuts Hepatic Steatosis in Obesity and T2DM Drugs
November 30, 2021Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are highly effective for reducing hepatic steatosis in patients with severe obesity and type 2 diabetes, with almost complete clearance of liver fat one year after surgery... -
Interventions More Likely After RYGB Versus Sleeve Gastrectomy drugs
January 16, 2020Among adults undergoing bariatric surgery, interventions, operations, and hospitalizations are more likely after Roux en Y gastric bypass (RYGB) than after sleeve gastrectomy (SG), according to a study published online Jan. 15 in?JAMA Surgery. -
Gastric Sleeve Tied to Lower Risk for Subsequent Procedures drugs
December 31, 2019Patients undergoing vertical sleeve gastrectomy (VSG) appear to be less likely than matched patients undergoing Roux-en-Y gastric bypass (RYGB) to experience subsequent abdominal operative interventions ...
Pharma Sources Insight January 2025
